Need to Evaluate Recruitment Performance of Trial Site Investigators

Inadequate public information is available about the recruitment performance of trial site investigators despite their importance to the success of multicentre clinical trials.

In this week's PLoS Medicine, Rafael Dal-Ré and colleagues argue that that sponsors should disclose the recruitment targets of all site investigators on ClinicalTrials.gov before a trial starts, as well as their final recruitment. Information on issues that could have affected recruitment should also be provided. This information will be of interest to different stakeholders such as patient organizations, sponsors, and MCT networks, say the authors.

Clinical Trials | Drug Trials - Types Protocol Development and Approval FAQs
Clinical trials are experiments that yield useful information to clinicians if a particular treatment is of any value to a patient.

The authors state that: "Disclosing all site investigators' recruitment figures could prompt queries to the sponsor from the scientific community about regional subgroup analyses, to be able to assess if ethnic or standard-of-care differences have an impact on treatment outcomes."

Source-Eurekalert

Clinical Trials - Early History
Many of the drugs that are used today have been discovered by chance or often by mere serendipity

Clinical Trials and Its different Phases
Clinical trials serve as a vital component for improving the treatment of medical conditions as they lead to higher standards of patient care.

Banned Drugs | Drugs Banned in India | List of Banned Drugs
Several drugs are either banned or withdrawn after introduction in the market.

Need to Evaluate Performance of Trial Site Investigators